Pieter Oldenziel

Director/Board Member at ABLYNX

Health Technology

Profile

Pieter Oldenziel has worked as a Director at Ablynx NV since 2019 and currently holds a position as Managing Director at Sanofi Foreign Participations BV.

Pieter Oldenziel active positions

Companies	Position	Start
ABLYNX	Director/Board Member	2018-12-31
Sanofi Foreign Participations BV Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Part of Sanofi, Sanofi Foreign Participations BV is a Dutch company that manufactures human monoclonal antibody drugs. The private company is based in Amsterdam, Netherlands. The company was founded in 1998. The CEO is Pieter Oldenziel.	Chief Executive Officer	-

All active positions of Pieter Oldenziel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pieter Oldenziel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Ablynx NV Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium.	Health Technology
Sanofi Foreign Participations BV Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Part of Sanofi, Sanofi Foreign Participations BV is a Dutch company that manufactures human monoclonal antibody drugs. The private company is based in Amsterdam, Netherlands. The company was founded in 1998. The CEO is Pieter Oldenziel.	Health Technology